Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023
   PCE(x) -970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is -970.75 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹114.6 Cr 3% -1.9% -12% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,892.7 Cr 2.7% 1.1% 40.3% Stock Analytics
KIRI INDUSTRIES ₹3,266.3 Cr 6.4% 0.4% 65.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,007.5 Cr -5.8% -5.7% -8.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,160.6 Cr 1.3% 16.8% 45.3% Stock Analytics
BODAL CHEMICALS ₹989.9 Cr 2.1% 11.3% -1.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

3%

-1.9%

-12%

SENSEX

-1.1%

1%

3.4%


You may also like the below Video Courses